Enter inventor name

EPO Patents = 1

Average Co-Inventor Count = 1.8

ph-index = 7

Forward Citations = 99(Granted Patents)

Location History:

Reigate, EN (1978)
Reigate, GB (1979 - 1980)
Betchworth, GB (1979 - 1997)
Harlow, GB (2005 - 2009)
Great Dunmow, GB (2000 - 2012)

Company Filing History:

Smithkline Beecham Corporation

Glaxosmithkline Istrazivacki Center Zagreb D.o.o

where one patent can have more than one assignee

Years Active: 1978-2012

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE43390 - Pleuromutilin derivatives as antimicrobials (2012-05-14),

2. 7547679 - Ether linked macrolides useful for the treatment of microbial infections (2009-06-16),

3. RE39128 - Pleuromutilin derivatives as antimicrobials (2006-06-12),

4. 7045619 - 2-(pyrazol-3-yl)carbapenem derivatives (2006-05-16),

5. 6972297 - 2-Hydroxy-mutilin carbamate derivatives for antibacterial use (2005-12-06),

6. 6878704 - Heterocyclic mutilin esters and their use as antibacterials (2005-04-12),

7. 6281226 - Pleuromutilin derivatives as antimicrobials (2001-08-28),

8. 6239175 - Carbamoyloxy derivatives of mutiline and their use as antibacterials (2001-05-29),

9. 6121281 - Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use (2000-09-19),

10. 5612477 - 2-(pyrazol-3-yl)carbapenem derivatives (1997-03-18),

11. 5606051 - 2-(pyrazol-3-yl)carbapenem derivatives (1997-02-25),

12. 4957905 - 9-(N'-substituted hydrazone) derivatives of erythromycins (1990-09-18),

13. 4921839 - Erythromycin a 11,12-carbonate 9-oxime derivatives (1990-05-01),

14. 4743593 - 9,11-O-methylene derivatives of 9-dihydroerythromycin (1988-05-10),

15. 4415584 - 3-Oxo-6-oxa-2-azatricyclo 5.4.2. unadecene-4-carboxylate (1983-11-15),

Title: Eric Hunt: Innovator in Antimicrobial Solutions

Introduction

Eric Hunt, located in Harlow, GB, is a prolific inventor with a remarkable portfolio consisting of 22 patents. His contributions to the field of antimicrobial therapy have positioned him as an influential figure in medical innovation.

Latest Patents

Among his latest inventions are the "Pleuromutilin derivatives as antimicrobials," which focus on the development of pleuromutilin derivatives. This invention encompasses processes for their preparation, pharmaceutical compositions containing them, and their application in medical therapy, particularly in combating bacterial infections. Another noteworthy patent is "Ether linked macrolides useful for the treatment of microbial infections." This invention relates to 14- or 15-membered macrolides substituted at the 4″ position, along with the processes for their preparation, aimed at treating systemic or topical microbial infections in both humans and animals.

Career Highlights

Eric has had a distinguished career, working with prominent companies such as Beecham Group Plc and SmithKline Beecham Corporation. His experience in these organizations has undoubtedly contributed to his expertise in the pharmaceutical sector.

Collaborations

Throughout his career, Eric has collaborated with notable figures including Steven Dabbs and Colin Henry Frydrych. These partnerships have fostered a collaborative environment that has facilitated innovation and development in their respective fields.

Conclusion

Eric Hunt remains a key player in the innovation of antimicrobial therapies, with his extensive patent portfolio solidifying his status as a leader in pharmaceutical research and development. His work continues to impact the medical community positively, paving the way for new treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com